Quantum Genesis AI Corp. (QGAI) stock
Close on Oct 19, 2026Market cap $1.43MP/E –Yield –
Quantum Genesis AI Corp. reported revenue of $0 for the twelve months to Apr 30, 2026. At the latest close the market valued the company at $1.43M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Apr 30, 2026
Valuation
- Market cap
- $1.43M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $0
- Net income
- -$4.44M
- EPS, diluted
- -$0.12
- Book value per share
- -$0.01
- Diluted shares
- 35M
Trading
- Previous close
- $0.06
- Open
- $0.03
- Day's range
- $0.03 – $0.04
- Volume
- 17,000
- Average volume (20 days)
- 30,789
Market cap history
Month-end market cap since 2024, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | QGAI | S&P 500 | Difference | QGAI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -69.9% | +0.6% | −70.5 pts | ||
| 3 months | -49.2% | +3.4% | −52.6 pts | ||
| Year to date | -98.6% | +13.3% | −111.9 pts | ||
| 1 year | -76.9% | +16.6% | −93.5 pts |
Seven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
About Quantum Genesis AI
Industrial Organic Chemicals
Quantumzyme Corp. is a biotransformation company that develops engineered enzymes focused on clean and green chemistry. The company designs biocatalysts to optimize active pharmaceutical ingredient production by replacing legacy chemical processes that use hazardous materials with environmentally sustainable alternatives. Its initial engineered enzyme product serves the pharmaceutical production of generic ibuprofen. Quantumzyme intends to license its technology to major pharmaceutical firms and active pharmaceutical ingredient manufacturers, while partnering with third-party organizations for large-scale manufacturing and distribution.
Company profile, executives and historyQuantum Genesis AI stock: common questions
What is Quantum Genesis AI's stock price?
QGAI closed at $0.04 on Oct 19, 2026, down 29.44% on the day.
What is Quantum Genesis AI's market cap?
Quantum Genesis AI was worth $1.43M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is QGAI's P/E ratio?
Quantum Genesis AI lost money over the twelve months to Apr 30, 2026 (diluted EPS -$0.12), so it has no meaningful P/E ratio.
How much revenue does Quantum Genesis AI make?
Quantum Genesis AI reported revenue of $0 for the twelve months to Apr 30, 2026.
Does Quantum Genesis AI pay a dividend?
No. Quantum Genesis AI has not paid a cash dividend over the last twelve months.
How has QGAI stock performed over the past year?
Including dividends, QGAI returned -76.9% over the past year, against +16.6% for the S&P 500.
Who are Quantum Genesis AI's competitors?
Companies most similar to Quantum Genesis AI by business, industry and size include CDXS, VGAS, BIOF, GWTI, WNDW.
See a number that looks wrong?